XML 37 R28.htm IDEA: XBRL DOCUMENT v3.22.0.1
2. REVENUE RECOGNITION (Details)
9 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]    
Revenue, Practical Expedient, Initial Application and Transition, Nondisclosure of Transaction Price Allocation to Remaining Performance Obligation [true false] true  
Revenue, Practical Expedient, Incremental Cost of Obtaining Contract [true/false] true  
Warranty period 3 years  
Net revenue | Customer Concentration Risk    
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]    
Concentration risk percentage 31.00% 40.00%
SARM Products | Net revenue | Customer Concentration Risk    
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]    
Concentration risk percentage 98.00%  
Minimum    
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]    
Payment terms 30 days  
Maximum    
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]    
Payment terms 60 days